Alert: GPs in England are now able to prescribe the medication Tirzepatide (Mounjaro) for weight loss.
Locally, the service for this is not up and running as yet. Please follow the link below to keep up to date with details as they are released.
Availability of the drug is being made available on a phased basis, with the first group of people eligible under the national criteria being people who:
Have a Body Mass Index (BMI) of 40 kg/m² or more (or 37.5 kg/m² for people from minority ethnic family backgrounds)
and
Have at least four of the following long-term conditions:
1. Type 2 diabetes
2. Hypertension (high blood pressure)
3. Dyslipidaemia
4. Established cardiovascular disease
5. Obstructive sleep apnoea
Click here to access more information
